O Papel da ANVISA nas Marcas de Medicamentos – complementar ou suplementar?
por Deborah Portilho
Revista UPpharma nº 143, ano 36, Novembro/Dezembro de 2013
por Deborah Portilho
Revista UPpharma nº 143, ano 36, Novembro/Dezembro de 2013
Deborah Portilho foi convidada a apresentar para os associados da Associação Brasileira da Propriedade Intelectual (ABPI) as propostas da ANVISA para a futura Resolução da Diretoria Colegiada (RDC) sobre os “Nomes Comerciais de Medicamentos” […]
Cookie | Duração | Descrição |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |